Thriva, a London, UK-based proactive health company, raised £4M in extension to its Series A funding.
The round, which brought total funding to £11m, was led by Target Global, with participation from existing investors Guinness Asset Management and Pembroke VCT.
The company intends to use the funds to expand adoption of its at-home health service.
Led by Hamish Grierson, co-founder and CEO, Thriva is a proactive health company which processes at-home blood tests for people to keep track of what’s happening inside their bodies. Thriva have processed over 115,000 test at-home blood tests since 2016.